
Sign up to save your podcasts
Or


This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421

136 Listeners

320 Listeners

496 Listeners

168 Listeners

882 Listeners

292 Listeners

3,351 Listeners

137 Listeners

1,147 Listeners

193 Listeners

93 Listeners

512 Listeners

369 Listeners

425 Listeners

374 Listeners